TMCnet News
IVD Market in China to Grow at a CAGR of 14.3% by 2021: Key Vendors are Roche Diagnostics, Abbott & Siemens Healthineers - Research and MarketsResearch and Markets has announced the addition of the "IVD Market in China 2017-2021" report to their offering. The in-vitro diagnostics (IVD) market in China to grow at a CAGR of 14.39% during the period 2017-2021. The report, In-vitro diagnostics (IVD) Market in China 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. The latest trend gaining momentum in the market is companion diagnostics. Companion diagnostics or simply CDx are the tests done to ensure safe and effective use of a corresponding drug or a biological product. It helps a healthcare professional to measure a therapeutic product's applicability on a specific individual. Thee tests are developed along with the manufacturing of the related drugs. Its application detects whether an individual is a right candidate for the particular therapy or not. These tests can be mainly seen in the oncology field where drugs are too expensive. Key vendors Other prominent vendors
Key Topics Covered: PART 01:Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction PART 05: Market landscape PART 06: Healthcare structure in China PART 07: Market segmentation by application PART 08: Market segmentation by end-user PART 09: Decision framework PART 10: Drivers and challenges PART 11: Market trends PART 12: Vendor landscape PART 13: Key vendor analysis PART 14: Appendix For more information about this report visit http://www.researchandmarkets.com/research/cdrcmg/ivd_market_in View source version on businesswire.com: http://www.businesswire.com/news/home/20170519005240/en/ |
